Hematologic Malignancies Update:Latest Developments in Diagnosis and Management

Registration Information

Date	Wednesday, October 7, 2015
Time	8:00 am Registration 8:30 am to 4:30 pm Course
Place	Samuel Merritt University Health Education Center 400 Hawthorne Avenue Oakland, CA 94609
CEU’s	6.75 Hours
Fee	$60.00 20% discount for 5 or more nurses registering from the same place of employment (registration forms must be submitted together)
	In accordance with the Americans with Disabilities Act, please advise coordinator of any disability requiring special accommodation prior to registering so appropriate modifications can be made.
Deadline	October 1, 2015

Confirmation

Will be sent via email upon receipt. 

Cancellation / Refund Policy

Space is limited, and registrations will be accepted in the order in which they are received. Map, discounted parking information and course confirmation letters will be sent via e-mail immediately upon receipt of application and payment. You must bring the confirmation with you to the course to be seated. If you have not received a confirmation within 5 days of registration, please contact the Bay Area Tumor Institute immediately. If you send/fax your registration within 5 business days or less of the registration deadline, please call the Bay Area Tumor Institute to confirm receipt. Without confirmation of receipt, you will not be admitted to the course after the deadline.

Bay Area Tumor Institute Nursing Committee

Nancee Hirano, RN, MS, ANP, AOCN^® , Coordinator of Core Courses
Ligaya Yadao, RN, MS, Committee Chair
Audrey Berman, PhD, RN
Patricia Calloway, RN, BSN
Maria Cho, RN, PHD
Nicole Gee, RN
Teri Gwin, RN, MS, GNP
Bev Hart-Inkster, RN, BSN, OCN
Cathy McCaughey, RN, MS
Dorothy Paiva, RN, MS
Angeles Price, RN, MS
Elaine Shingleton, RN, MS
Shannon Wirth, RN

Barry B. Siegel, President

Bay Area Tumor Institute

The Bay Area Tumor Institute is dedicated to improving the care of cancer patients in the Bay Area. Each year, the Institute provides more than 100 hours of continuing education for nurses and other members of the cancer care team. The Institute also provides consultations to physicians treating difficult or unusual head and neck cancer cases and, through its clinical research program, provides advanced anti-cancer drugs to patients on investigational treatment protocols. The Institute also provides opportunities for those "at risk" to participate in breast cancer and prostate cancer prevention trials.